ArticleCommunications biology2022

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model.

Ismail M Meraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.